Albert D. Bolles
Equibles does not estimate personal net worth.
About Albert D. Bolles
Earlier roles on record: Board Member at Arcadia Biosciences, Inc. (RKDA) until February 4, 2026 and Board Member at Lifecore Biomedical, Inc. De (LFCR) until August 10, 2022. Arcadia Biosciences, Inc. reported in an 8-K filed February 6, 2026 that Albert D. Bolles resigned as director, effective February 4, 2026. The same filing states: “Their resignation was not because of any disagreement with the Company or the Board on any matter relating to the Company’s operations, policies, practices or financial statements.” Lifecore Biomedical, Inc. De reported in an 8-K filed August 10, 2022 that Albert D. Bolles resigned as director of the Board of Directors, effective August 10, 2022. Lifecore Biomedical, Inc. De reported in an 8-K filed August 10, 2022 that Albert D. Bolles resigned as Chief Executive Officer, effective August 10, 2022. The proxy statement of Lifecore Biomedical, Inc. De reports total compensation of $956,810 for Albert D. Bolles in fiscal 2022, including a base salary of $655,547. Disclosed compensation is on record for 4 fiscal years.
“On February 4, 2026, each of Albert D. Bolles, Ph.D., a director and member of the Compensation Committee of the board of directors (the "Board") of Arcadia Biosciences, Inc. (the "Company"), and Deborah Carosella, a director and member of the Compensation Committee and Nominating and Governance Committee of the Board, notified the Company that effective as of February 4, 2026, such person was resigning as a director of the Company and all subsidiaries of the Company of which such person was a director.”
“Their resignation was not because of any disagreement with the Company or the Board on any matter relating to the Company’s operations, policies, practices or financial statements.”
“In accordance with the Separation Agreement, Dr. Bolles resigned as the Company's Chief Executive Officer and as a director of the Board of Directors of the Company (the "Board), effective immediately, to transition to serve as President of Curation Foods, Inc., a wholly owned subsidiary of the Company.”
Affiliation history
-
2014-01-01–2022-08-10
-
Start not stated–2026-02-04
Company network
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2014-01-01–2022-08-10
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Lifecore Biomedical, Inc. De (LFCR) | Former President and Chief Executive Officer | $655,547 | $956,810 |
| 2021 | Lifecore Biomedical, Inc. De (LFCR) | Former President and Chief Executive Officer | $633,592 | $1,131,299 |
| 2020 | Lifecore Biomedical, Inc. De (LFCR) | Former President and Chief Executive Officer | $620,000 | $980,309 |
| 2019 | Lifecore Biomedical, Inc. De (LFCR) | President and Chief Executive Officer | $4,769 | $1,004,966 |
Recent activity
-
Executive change Resigned: director
“Their resignation was not because of any disagreement with the Company or the Board on any matter relating to the Company’s operations, policies, practices or financial statements.”
Arcadia Biosciences, Inc. (RKDA) -
-